J. Westin

发表

Seasonal changes in plasma levels of LH and gonadal steroids in free-living Willow Tits Parus montanus

B. Silverin, P. Viebke, J. Westin, 1986 .

Serum deoxythymidine kinase: no help in the diagnosis and prognosis of monoclonal gammopathy

R. Jagenburg, J. Westin, H. Bäck, 1993, British journal of haematology.

Decline of blood haemoglobin in the aged: a longitudinal study of an urban Swedish Population from age 70 to 81

S. Landahl, A. Svanborg, R. Jagenburg, 1989, British journal of haematology.

Cost–utility analysis of high‐dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myeloma

E. Nord, S. Lenhoff, F. Wisløff, 2001, European journal of haematology.

Bone marrow progenitor cell growth and karyotype changes in healthy 88‐year‐old subjects

H. Nilsson‐Ehle, B. Swolin, J. Westin, 1995, European journal of haematology.

Seasonal changes in body weight, fat depots, and plasma levels of thyroxine and growth hormone in free-living great tits (Parus major) and willow tits (P. montanus).

C. Scanes, B. Silverin, P. Viebke, 1989, General and comparative endocrinology.

Seasonal changes in mass and histology of the spleen in Willow Tits Parus montanus

R. Fänge, B. Silverin, P. Viebke, 1999 .

Plasma levels of luteinizing hormone and steroid hormones in free-living winter groups of willow tits (Parus montanus)

B. Silverin, P. Viebke, J. Westin, 1984, Hormones and Behavior.

Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: Prospective study of efficacy and leukaemogenicity with therapeutic implications

B. Swolin, J. Westin, A. Weinfeld, 1994, European journal of haematology.

Primary gastrointestinal lymphoma incidence, clinical presentation, and surgical approach

B. Gustavsson, B. Ridell, J. Westin, 1986, Journal of surgical oncology.

Clinical utility of immunoglobulin heavy chain gene rearrangement identification for tumour cell detection in multiple myeloma

S. Lenhoff, T. Olofsson, B. Thuresson, 1998, British journal of haematology.

Hormonal correlates of migration and territorial behavior in juvenile willow tits during autumn.

B. Silverin, P. Viebke, J. Westin, 1989, General and comparative endocrinology.

Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy.

B. Barlogie, M. Dimopoulos, P. Sonneveld, 2009, Blood.

Renal function in newly diagnosed multiple myeloma — A demographic study of 1353 patients

E. Holmberg, L. Knudsen, J. Westin, 1994, European journal of haematology.

Interferon alfa‐2b versus no maintenance therapy during the plateau phase in multiple myeloma: a randomized study

A. Cortelezzi, I. Turesson, J. Westin, 1995, British journal of haematology.

Initial treatment in multiple myeloma: no advantage of multidrug chemotherapy over melphalan‐prednisone

E. Holmberg, J. Westin, B. Magnusson, 1990, British journal of haematology.

Initial versus deferred melphalan‐prednisone therapy for asymptomatic multiple myeloma stage I — A randomized study

E. Holmberg, J. Westin, B. Magnusson, 1993, European journal of haematology.

Bone marrow in vitro growth and cytogenetic studies in patients with fab‐classified primary myelodysplastic syndromes

B. Swolin, J. Westin, S. Rödjer, 1990, American journal of hematology.

Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double‐blind placebo‐controlled trial

J. Ford, N. Abildgaard, I. Turesson, 1998, British journal of haematology.

Survival in conventionally treated younger (<60 years) multiple myeloma patients: no improvement during two decades

E. Holmberg, I. Turesson, J. Westin, 1999, European journal of haematology.

A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course.

J. Westin, B. Swolin, J. Westin, 1988, Blood.

Trisomy 1q in polycythemia vera and its relation to disease transition

J. Westin, B. Swolin, J. Westin, 1986, American journal of hematology.

Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival : an analysis of 10 549 patients from the International Myeloma Working Group

B. Barlogie, M. Dimopoulos, P. Sonneveld, 2008 .

Influence of the Opposite Sex on Photoperiodically Induced LH and Gonadal Cycles in the Willow Tit (Parus montanus)

B. Silverin, J. Westin, 1995, Hormones and Behavior.

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

B. Barlogie, M. Dimopoulos, H. Einsele, 2010, Leukemia.

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group

U. Mellqvist, M. Dimopoulos, H. Einsele, 2016, Leukemia.

Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors

E. Holmberg, A. Waage, A. Odén, 1999, British journal of haematology.

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease.

A. Waage, A. Sundan, N. Abildgaard, 2001, Blood.

Cytogenetic studies of bone marrow and extramedullary tissues and clinical course during metamorphosis of chronic myelocytic leukemia.

J. Westin, J. Waldenström, J. Waldenström, 1983, Cancer genetics and cytogenetics.

Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation

M. Höglund, B. Johansson, F. Mitelman, 2002, European journal of haematology.

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.

H. Johnsen, E. Holmberg, J. Lamvik, 2000, Blood.

An artificial simulation of the vernal increase in day length and its effects on the reproductive system in three species of tits (Parus spp.), and modifying effects of environmental factors ― a field experiment

B. Silverin, P. Viebke, J. Westin, 1989 .

The effect of alpha-interferon on bone marrow megakaryocytes and platelet production rate in essential thrombocythemia.

P. Révész, J. Westin, B. Ridell, 1991, Blood.

Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group.

B. Barlogie, P. Sonneveld, M. Boccadoro, 2008, Blood.